Francois Vrtovsnik
Overview
Explore the profile of Francois Vrtovsnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathurin M, Hirsch P, Jachiet V, Hadjadj J, Le Guenno G, Heiblig M, et al.
Kidney Int Rep
. 2025 Jan;
10(1):260-264.
PMID: 39810778
No abstract available.
2.
Cortes Garcia E, Giarraputo A, Racape M, Goutaudier V, Ursule-Dufait C, De La Grange P, et al.
Transplantation
. 2024 Oct;
PMID: 39441708
Background: In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identify clinically relevant archetypes. Methods:...
3.
Chalouni M, Loubet P, Lhomme E, Ninove L, Barrou B, Blay J, et al.
BMC Infect Dis
. 2024 Sep;
24(1):1049.
PMID: 39333909
Background: We assessed the prognostic value of serological humoral markers measured one month after the last dose of the primary COVID-19 vaccine course for predicting the risk of severe acute...
4.
Cortes Garcia E, Giarraputo A, Racape M, Goutaudier V, Ursule-Dufait C, De La Grange P, et al.
Transpl Int
. 2024 Jul;
37:13043.
PMID: 39050190
Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involved in rejection....
5.
6.
Motiejunaite J, Flamant M, Arnoult F, Lahens A, Tabibzadeh N, Boutten A, et al.
Hypertens Res
. 2024 Jul;
47(9):2511-2520.
PMID: 38969804
Increasing attention has recently been paid to discrepancies between office and ambulatory blood pressure (BP) control in patients with chronic kidney disease (CKD), but information on mechanisms underlying circadian BP...
7.
Legrand F, Motiejunaite J, Arnoult F, Lahens A, Tabibzadeh N, Robert-Mercier T, et al.
J Hypertens
. 2024 Apr;
42(6):1000-1008.
PMID: 38647162
Objectives: Optimal blood pressure (BP) control is key to prevent cardiovascular complications in patients with chronic kidney disease (CKD). We described the prevalence and factors associated with masked hypertension in...
8.
Gleeson P, Benech N, Chemouny J, Metallinou E, Berthelot L, Da Silva J, et al.
Sci Transl Med
. 2024 Mar;
16(740):eadl6149.
PMID: 38536935
Mechanisms underlying the disruption of self-tolerance in acquired autoimmunity remain unclear. Immunoglobulin A (IgA) nephropathy is an acquired autoimmune disease where deglycosylated IgA1 (IgA subclass 1) auto-antigens are recognized by...
9.
Michon-Colin A, Metzger M, Bankir L, Gauci C, Brunel M, Baron S, et al.
Clin Kidney J
. 2023 Dec;
16(12):2472-2481.
PMID: 38046034
Background: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to...
10.
Caillard P, Vigneau C, Halimi J, Hazzan M, Thervet E, Heitz M, et al.
Front Immunol
. 2023 Jul;
14:1190394.
PMID: 37475859
Background And Objectives: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney...